Journal of Vascular and Interventional Radiology
Volume 20, Issue 7, Supplement , Pages S474-S485 , July 2009

Research Reporting Standards for Percutaneous Thermal Ablation of Lung Neoplasms

  • Steven C. Rose, MD

      Affiliations

    • Section of Interventional Oncology, Department of Radiology, University of California San Diego Medical Center, San Diego, California
    • Corresponding Author InformationAddress correspondence to S.C.R., c/o Tricia McClenny, Society of Interventional Radiology, 3975 Fair Ridge Dr., Suite 400 N., Fairfax, VA 22033
    • ,
  • Damian E. Dupuy, MD

      Affiliations

    • Department of Diagnostic Imaging, Brown Medical School, Rhode Island Hospital, Providence, Rhode Island
    • ,
  • Debra A. Gervais, MD

      Affiliations

    • Gastrointestinal/Genitourinary Division, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • Steven F. Millward, MD

      Affiliations

    • Department of Radiology, University of Western Ontario, London
    • Department of Radiology, Peterborough Regional Health Centre, Peterborough, Ontario, Canada
    • ,
  • Daniel B. Brown, MD

      Affiliations

    • Division of Interventional Radiology, Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
    • ,
  • John F. Cardella, MD

      Affiliations

    • Department of Radiology, Geisinger Health System, Danville, Pennsylvania
    • ,
  • Michael J. Wallace, MD

      Affiliations

    • Department of Interventional Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • Technology Assessment Committee of the Society of Interventional Radiology

Received 8 December 2008 ,Revised 5 January 2009 ,Accepted 5 January 2009.

References 

  1. Jemal A, Taylor M, Ward E, et al. Cancer statistics 2005. CA Cancer J Clin. 2005;55:10–30
  2. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin. 1994;44:7–26
  3. American Cancer Society. Cancer facts and figures 2005. Atlanta, GA: American Cancer Society; 2005;
  4. Burt M, Martini N, Ginsberg RJ. Surgical treatment of lung carcinoma. In:  Baue AE editors. Glenn's thoracic and cardiovascular surgery, sixth edition. Stamford, CT: Appleton & Lange; 1996;p. 421–443
  5. Willis RA. Secondary tumours of the lungs. In:  Willis RA editors. The spread of tumours in the human body. London: Butterworths; 1973;p. 167–174
  6. Dupuy DE, Zagoria RJ, Arercey W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol. 2000;174:57–59
  7. Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg. 2003;125:929–937
  8. Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results. Radiology. 2003;229:821–829
  9. Steinke K, King J, Glenn D, Morris DL. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr. 2003;27:750–757
  10. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231:850–857
  11. Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer-a preliminary report of 33 patients. AJR Am J Roentgenol. 2004;183:1003–1011
  12. Kang S, Luo R, Liao W, Wu H, Zhang X, Meng Y. Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment positron emission tomography in lung tumours. World J Surg Oncol. 2004;2:30–35
  13. Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology. 2004;230:125–134
  14. Gadaleta C, Mattioli V, Colucci G, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol. 2004;183:361–368
  15. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol. 2004;15:463–470
  16. Jin GY, Lee JM, Lee YC, Ha YM, Lim YS. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up CT. AJR Am J Roentgenol. 2004;183:1013–1020
  17. Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol. 2005;185:466–471
  18. van Sonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol. 2005;184:381–390
  19. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg. 2005;129:639–644
  20. Nguyen CL, Scott WJ, Young NA, Rader T, Giles LR, Goldberg M. Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest. 2005;128:3507–3511
  21. Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small cell lung cancer. J Vasc Interv Radiol. 2006;17:1117–1124
  22. Ambrogi MC, Fontanini G, Cioni R, Faviana P, Fanucchi O, Mussi A. Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study. J Thorac Cardiovasc Surg. 2006;131:1002–1006
  23. Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumors: results in the mid-term. Eur J Cardiothorac Surg. 2006;30:177–183
  24. Yamagami T, Kato T, Hirota T, Yoshimatsu R, Matsumoto T, Nishimura T. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms. J Vasc Interv Radiol. 2006;17:1625–1629
  25. Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors; incidence and risk factors. Radiology. 2006;241:275–283
  26. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol. 2006;13:1529–1537
  27. Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest. 2006;129:639–644
  28. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Learning curve for percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: a prospective study of 70 consecutive cases. Ann Surg Oncol. 2006;13:1588–1595
  29. de Baere T, Palussiere J, Auperin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240:587–589
  30. Kawamura M, Izumi Y, Tsukada N, et al. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia in nonsurgical candidates. J Thorac Cardiovasc Surg. 2006;13:1007–1013
  31. He W, Hu X, Wu D, et al. Ultrasonography-guided percutaneous microwave ablation of peripheral lung cancer. Clin Imaging. 2006;30:234–241
  32. Simon CJ, Dupuy DE, Dipetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243:268–278
  33. Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol. 2007;18:393–398
  34. Okuma T, Matsuoka T, Yamamoto A, et al. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol. 2007;18:399–404
  35. Wolf FJ, Grand DJ, Machan JT, DiPetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008;247:871–879
  36. Hiraki T, Mimura H, Gobara H, et al. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?. J Vasc Interv Radiol. 2008;19:706–711
  37. Gillams AR, Lees WJ. Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol. 2008;18:672–677
  38. Lencioni RA, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intent-to-treat, multicenter trial (the RAPTURE study). Lancet Oncol. 2008;9:621–628
  39. Deslauriers J. Current surgical treatment of nonsmall cell lung cancer 2001. Eur Respir J. 2002;19(suppl):61S–70S
  40. Ginsberg RJ, Rubinstein LV Lung cancer study group. Randomized trial of lobectomy versus limited resection for T1N0 nonsmall cell lung cancer. Ann Thorac Surg. 1995;60:615–623
  41. Landereneau RJ, Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage I (T1,N0, M0) non-small cell lung cancer. J Thorac Cardiovasc Surg. 1997;113:691–698
  42. Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastasis: a 20-year experience. Ann Thorac Surg. 1984;38:323–330
  43. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases (The International Registry of Lung Metastases, Writing Committee). J Thorac Cardiovasc Surg. 1997;113:37–49
  44. Landreneau RJ, DeGiacomo T, Mack MJ, et al. Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases. Eur J Cardiothorac Surg. 2000;18:671–677
  45. Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg. 2002;124:1007–1013
  46. Friedel G, Pastorino U, Ginsberg RJ, et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the international registry of lung metastases. Eur J Cardiothorac Surg. 2002;22:335–344
  47. Goldberg SN, Grassi CJ, Cardella JF, et al. Society of Interventional Radiology Technology Assessment Committee and the Interventional Working Group on Image-Guided Tumor Ablation Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2005;16:765–778
  48. Goldberg SN, Grassi CJ, Cardella JF, et al. Society of Interventional Radiology Technology Assessment Committee and the Interventional Working Group on Image-Guided Tumor Ablation Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235:728–739
  49. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2005;14(suppl):S199–S202
  50. National Cancer Institute. Common Terminology Criteria for Adverse Events v 3.0 (CTCAE). August 9, 2006 Bethesda, MD: National Cancer Institute, National Institutes of Health; 2006;
  51. Yamamoto A, Nakamura K, Matsuoka T, et al. Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings. AJR Am J Roentgenol. 2005;185:1299–1309
  52. Bojarsky JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol. 2005;185:466–471
  53. van Sonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience—technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol. 2005;184:381–390
  54. Solomon SB, Thornton RH, Dupuy DE, Downey RJ. Protection of the mediastinum and chest wall with an artificial pneumothorax during lung ablation. J Vasc Interv Radiol. 2008;19:610–615
  55. Chopra S, Dodd GD, Chintapalli KN, Leyendecker JR, Karahan OI, Rhim H. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR Am J Roentgenol. 2001;177:381–387
  56. Meloni MF, Goldberg SN, Livraghi T, et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast – enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol. 2001;177:375–380
  57. Swenson SJ, Viggioano RW, Midthan DE, et al. Lung nodule enhancement at CT: a multicenter study. Radiology. 2000;214:73–80
  58. Golstraw P, Crowley J, Chansky K, et al. International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions The IASLC Lung Cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2:706–714

 S.C.R. is a stockholder in Boston Scientific (Natick, Massachusetts). D.E.D. has received grant support from Endocare (Irvine, California), Veran Medical (St. Louis, Missouri), Angiodynamics (Queensbury, New York), Biotex (Houston, Texas), PneumRx (Mountain View, California), and Medwaves (San Diego, California); serves as a consultant for Ethicon (Somerville, New Jersey), BSD Medical (Salt Lake City, Utah), and Medwaves (San Diego, California); and has received honoraria from Covidien (Mansfield, Massachusetts). D.A.G. has received research funding and serves as a speaker for Covidien (Mansfield, Massachusetts). M.J.W. has received honoraria and research funding from Siemens Medical Solutions (Erlangen, Germany). None of the other authors have identified a conflict of interest.

PII: S1051-0443(09)00018-9

doi: 10.1016/j.jvir.2009.01.016

Journal of Vascular and Interventional Radiology
Volume 20, Issue 7, Supplement , Pages S474-S485 , July 2009

Article Tools